Adherence with topical treatment is poor compared with adherence with oral agents: Implications for effective clinical use of topical agents - 09/08/11
Supported by a grant from Astellas Pharma Inc Disclosure: Dr Feldman has received research, speaking, and/or consulting support from Astellas Pharma Inc, Connetics, Galderma, Amgen, Biogen, and Genentech. Dr Fleischer has received research, speaking, and/or consulting support from Astellas Pharma Inc and Novartis Pharmaceuticals Corp. |
Vol 54 - N° 5S
P. S235-S236 - mai 2006 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?